Sitemap

US Abbott Laboratories launches test to detect COVID-19 in 5 minutes

More...

U.S. Adds $20.3 Million In New Funds For Assistance To Serbia

The United States Government announced an additional...

Serbia Most Sought After By Foreign Automakers

The investment in the automotive sector of...

News

70 Million Euros Of Non-Refundable Donations To Serbia Signed

The agreement worth EUR 70 million was signed today by the Head of the EU Delegation to Serbia, Ambassador...

Day Of Serbian Diplomacy Marked

On the Day of Diplomacy, Minister of Foreign Affairs Ivica Dačić presented tennis player Novak Djoković with an award...

Austria Donates Funds To Serbia To Fight COVID-19

Austrian Federal Minister for Europe, Integration and Foreign Affairs Alexander Schallenberg and EU and Constitution Minister Karoline Edtstadler attended...

Air Serbia To Increase The Number Of Flights In June

The national airline of Serbia, Air Serbia, due to increased demand, will increase the number of flights on certain...

Audience-attended Outdoor Sporting Events To Start On 1 June

The crisis response team for fighting COVID-19 made new decisions today in accordance with the current epidemiological situation in...

Abbott Laboratories has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes

What makes this test so different is where it can be used: outside the four walls of a traditional hospital such as in the physicians’ office or urgent care clinics.

The new Abbott ID NOW COVID-19 test runs on Abbott’s ID NOWTM platform—a lightweight box (6.6 pounds and the size of a small toaster) that can sit in a variety of locations.

Because of its small size, it can be used in more non-traditional places where people can have their results in a matter of minutes, bringing an alternate testing technology to combat the novel coronavirus.

Abbott is ramping up production to deliver 50,000 ID NOW COVID-19 tests per day to the U.S. healthcare system.

Testing remains a crucial step in controlling the novel COVID-19 pandemic. Continuing to supply healthcare providers with new technologies to help curb the spread of infection is a top priority for public health officials and healthcare providers.

Taking molecular testing to the front lines

Molecular point-of-care testing for COVID-19 offers healthcare workers rapid results in more settings where people show up for care. Molecular testing technologies help detect the presence of a virus by identifying a small section of the virus’ genome, then amplifying that portion until there’s enough for detection. This process can cut testing wait time from hours, if not days, to as little as five minutes for positive results and 13 minutes for negative results.

Day Of Serbian Diplomacy Marked

On the Day of Diplomacy, Minister of Foreign Affairs Ivica Dačić presented tennis player Novak Djoković with an award for exceptional personal engagement and...

Austria Donates Funds To Serbia To Fight COVID-19

Austrian Federal Minister for Europe, Integration and Foreign Affairs Alexander Schallenberg and EU and Constitution Minister Karoline Edtstadler attended the handover of aid from...

Air Serbia To Increase The Number Of Flights In June

The national airline of Serbia, Air Serbia, due to increased demand, will increase the number of flights on certain routes to which it is...

Audience-attended Outdoor Sporting Events To Start On 1 June

The crisis response team for fighting COVID-19 made new decisions today in accordance with the current epidemiological situation in Serbia From 1 June, all citizens...

Slovakia Supports Serbia’s Fight Against COVID-19

The newly appointed ambassador of the Slovak Republic in Belgrade, Fedor Rosocha, handed over a check in the amount of 10,000 euros to the...